# Anthropic IPO Stands Alone as AI Market Jitters Sideline Others

> Anthropic's AI IPO moves forward while rivals delay amid market volatility.
- Title: Anthropic IPO Stands Alone as AI Market Jitters Sideline…
- Summary: Anthropic's AI IPO moves forward while rivals delay amid market volatility. Anthropic plans its IPO in November despite AI market downturn, while competitors…
- Keywords: anthropic, ai market, ipo, technology, market volatility, switch, nscale, sec, money, business, Stands, Alone
- Source: The Economic Times — https://economictimes.indiatimes.com/markets/us-stocks/news/anthropic-ipo-stands-alone-as-ai-market-jitters-sideline-others/articleshow/135121938.cms
- Author: Reuters
- Published: 2026-10-22T15:16:00+00:00
- Read time: 1 min
- Topics: anthropic, ai market, ipo, technology, market volatility, switch, nscale, sec, money, business
## Anthropic IPO Timeline
Anthropic plans its IPO in November after publishing prospectus in late October, though dates may change.
## AI Market Turbulence
AI sector faces pullback with IPO delays and withdrawals since September due to rising interest rates and market volatility.
## Competitor Delays
Switch, Nscale, and SB Energy postponed IPOs amid regulatory scrutiny and concerns about AI spending sustainability.
## Investor Confidence
Many large investors remain bullish on Anthropic despite market turbulence, viewing it as a key AI exposure opportunity.
## Regulatory Scrutiny
Nscale's delay was partly due to SEC comments, while Switch filed confidentially to work with regulators before public disclosure.
## Market Concerns
Concerns about AI spending sustainability and competition from open-source models weigh on the sector despite investor confidence.
## IPO Impact
Anthropic's IPO tests whether its $1.5 trillion valuation potential can overcome market conditions typically prompting IPO delays.
## Key takeaway

Anthropic plans its IPO in November despite AI market downturn, while competitors like Switch and Nscale postpone listings due to rising interest rates and regulatory scrutiny.